Form 8-K - Current report:
SEC Accession No. 0001213900-24-086623
Filing Date
2024-10-09
Accepted
2024-10-09 16:15:07
Documents
13
Period of Report
2024-10-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea021719901-8k_aditxt.htm   iXBRL 8-K 27374
  Complete submission text file 0001213900-24-086623.txt   202750

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE adtx-20241003.xsd EX-101.SCH 3009
3 XBRL LABEL FILE adtx-20241003_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE adtx-20241003_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT ea021719901-8k_aditxt_htm.xml XML 3786
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 241362936
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)